A Randomized, Double-Blind Phase 3 Study of Ibrutinib in Combination With Corticosteroids versus Placebo in Combination With Corticosteroids in Subjects with New Onset Chronic Graft Versus Host Disease (cGVHD)
This Study is
No Longer Enrolling
Details
Age
Child to Adult
Phase
III - Research Studies that gather more information about a drug's safety and effectiveness by studying different populations and different dosages and by using the drug in combination with other drugs. These studies typically involve more participants.
Type of Study
Supportive Care
Locations
Childrens Hospital Colorado
Study ID
Protocol Number: 17-0396
More information available at ClinicalTrials.gov: NCT02959944
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers